Professor Amos D. Korczyn is the Sieratzki Professor of Neurology at Tel-Aviv University. Professor Korczyn graduated from the Hebrew University – Hadassah Medical School in Jerusalem in 1966 (MD), where he also received an MSc degree in pharmacology (cum laude) in 1966. He trained in neurology at Beilinson Hospital and at the National Hospital for Nervous Diseases in Queen Square, London. He was the Chairman of the Department of Neurology at the Tel-Aviv Medical Center since 1981 until 2002. Professor Korczyn has a particular interest in dementia. He has authored or co-authored over 600 articles in peer-reviewed journals, as well as chapters in books, etc. Professor Korczyn is or has been an Editorial Board member of 15 international journals, and organized several neurological conferences, mainly in the field of dementia, Parkinson’s disease and other degenerative brain disorders.

Perry received his bachelors of arts degree in zoology with high honors from University of California, Santa Barbara. After graduation, he headed to Scripps Institution of Oceanography and obtained his Ph.D. in marine biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Dr. Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures. In 1982, Perry joined the faculty of Case Western Reserve University, where he currently holds an adjunct appointment. He is distinguished as one of the top Alzheimer’s disease researchers with over 800 publications, one of the top 100 most-cited scientists in neuroscience and behavior and one of the top 25 scientists in free radical research. Perry has been cited over 23,000 times and is recognized as an ISI highly cited researcher. Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences and past-president of the American Association of Neuropathologists, as well as a member of the Dana Alliance for Brain Initiatives. Perry is recognized internationally for his work. He is a Foreign Correspondent Member of the Spanish Royal Academy of Sciences and a Foreign Member of the Mexican National Academy of Sciences, and recent recipient of the National Plaque of Honor from the Republic of Panama Ministry of Science and Technology.

Dr. Eric Tangalos is Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He was Chair of Primary Care Internal Medicine from 1997 to 2006. Dr. Tangalos received his undergraduate training from the University of Michigan, is a graduate of the Loyola University Stritch School of Medicine in Chicago, and was a resident and fellow in Internal Medicine at Mayo. He served eight years on the National Board of the Alzheimer’s Association and was a member of their Executive Committee. He continues as Co-Director of Education for the Mayo Clinic Alzheimer’s Disease Research Center and has been continuously funded by the National Institutes of Health since 1987. He is part of the original group to publish on Mild Cognitive Impairment.

Piotr Lewczuk, leads the Laboratory for Clinical Neurochemistry and Neurochemical Dementia Diagnostics at the Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen. This lab is one of the mostly internationally-recognized, European leading centers for neurochemical diagnosis of dementia. The Laboratory is one of the five world-wide reference centers, together with the laboratories in Göteborg (S), Amsterdam (NL), Ghent (B), and Philadelphia (USA), in the \"Alzheimer\'s Association\"-supported project on CSF biomarkers international quality control. He is a member of the Steering Committee of this project. For more than ten years he has been working on diagnostic and research aspects of the CSF, including a large panel of neurologic and psychiatric disorders with a particular scope on neurodegenerating conditions, like Alzheimer\'s disease. In 2004, he obtained the Certificate of Expertise from the German Society of Clinical Neurochemistry, to become one of seventy certified clinical neurochemists in Germany, and currently he is a member of the Extended Board of the German Society of Clinical Neurochemistry.

Dr. Buchanan is a board certified specialist in both neurological surgery and psychiatry. He is trained in and performs all aspects of neurosurgery including those for disorders of the brain, spine, and peripheral nerves. Dr. Buchanan also has subspecialty training and surgical expertise in epilepsy, deep brain stimulation, Parkinson\\\'s disease, essential tremor, Tourette syndrome, and dystonia, as well as pain syndromes and psychiatric disorders such as major depression and OCD. Dr. Buchanan is dedicated to helping patients recover both physically and psychologically. Dr. Buchanan completed his residencies at the University of California San Diego (UCSD) School of Medicine in the Department of Psychiatry and the Department of Surgery/Neurosurgery. His fellowships include Yale University School of Medicine, Department of Neurosurgery, in Epilepsy Surgery and Functional Neurosurgery; UCSD Department of Psychiatry and the National Institute of Health (NIH) Psychobiology and Psychopharmacology as well as The Salk Institute for Biological Studies, Post-Doctoral Fellow with the Lab of Genetics. Dr. Buchanan is an Associate Professor in the Department of Psychology and The Institute for Neuroscience at The University of Texas at Austin and The University of Texas Southwestern Medical School. He has an Image Guided Transcranial Laboratory at UT where he studies Brain Function and is exploring treatments for epilepsy, psychiatric disease, and movement disorders. Dr. Buchanan is a Board Certified Diplomate of both the American Board of Neurological Surgery and the American Board of Psychiatry and Neurology.

Fangyu Peng, M.D., Ph.D., is a physician-scientist who practices clinical nuclear medicine, with research interests in PET translational imaging and cancer therapy. Dr. Peng is studying copper metabolism as a target for metabolic imaging and therapy of cancers, including prostate cancer and hepatocellular carcinoma. Dr. Peng is also conducting translational research in molecular imaging of inherited and acquired copper metabolism disorders in Wilson\\\'s disease, Alzheimer\\\'s disease, and traumatic brain injury.

Eef Hogervorst did her Ph.D. at Maastricht University in age related cognitive decline and treatment at the Department of Psychiatry and Neuropsychology in 1998. She was subsequently employed at the University of Oxford (Oxford Project to Investigate Memory and Ageing, OPTIMA) as a neuropsychologist and epidemiologist and was awarded several grants and prizes for her research into early diagnoses and risk factors for dementia and cognitive decline. Eef did similar research as a Research Associate Professor at the Donald W. Reynolds Department of Geriatrics (ranked 8th nationally) of the University of Arkansas Medical Sciences and at the University of Cambridge (Department of Psychiatry) as Senior Research Associate, before taking on a Chair in Psychology at Loughborough University which is consistently ranked among the top Universities in the U.K. Eef has set-up collaborations with several large multi-centre observational and treatment studies for age related cognitive decline and dementia (EPIC NORFOLK and MRC CFAS in the U.K. and the H ABC, WHIMS and KEEPS studies in the U.S.A and a large cohort in Indonesia). She studies cross cultural clinical diagnostic accuracy of different types of dementias and has developed and validated a computerized expert system and cognitive test battery for this purpose with Dr Bandelow.  Eef is an elected member of the MRC College of Experts for Neuroscience and Mental Health, a member of the European Scientific Referee panel for the European Research Area in Ageing and is often asked to review research proposals (Alzheimer Association, NWO, SPARC etc) and papers in her field (Neurology, JNNP, Arch Neurol, etc). She was invited as a keynote speaker at several conferences (e.g. ICAD). At Oxford Eef was Somerville Junior Research fellow and Blasschko fellow at Linacre College. Eef is an elected young Fellow at the Royal Society of Medicine in London, Editor (Section Head) of the International Faculty 1000, on the editorial board of JAD and has over 100 international  peer reviewed publications.

Eef research interests are early diagnoses and modifiable risk and protective factors (e.g. hormones, exercise and nutrition) for dementia and age related cognitive decline; development and validation of cognitive tests and computerized diagnostic systems.

Lydia Gimenez Llort graduated in biology continued with the doctoral and postdoctoral three years at the Karolinska Institute in Sweden. She is now a researcher in neuroscience (aging and neurodegenerative diseases such as Alzheimer's) and professor in psychiatry at the Autonomous University of Barcelona.

Alzheimer's Disease, Animal Models, Neurodegenerative Diseases, Cognition Disorders Cognitive Neuroscience, Behavioral Neuroscience Neuropharmacology, Behavioral Testing Behavioral Analysis, Rat Handling, Behavioral, Pharmacology, Maze Learning, Microdialysis, Neurologic Kindling, Neuropsychopharmacology, Behavioral Neuroendocrinology, Brain